CovidResearchTrials by Shray Alag


CovidResearchTrials Covid 19 Research using Clinical Trials (Home Page)


Report for D012887: Skull Fractures NIH

(Synonyms: Skull Fractures)

Developed by Shray Alag
Clinical Trial MeSH HPO Drug Gene SNP Protein Mutation


Correlated Drug Terms (1)


Name (Synonyms) Correlation
drug918 Facial fractures reduction or osteosynthesis Wiki 1.00

Correlated MeSH Terms (1)


Name (Synonyms) Correlation
D008446 Maxillofacial Injuries NIH 1.00

Correlated HPO Terms (0)


Name (Synonyms) Correlation

There is one clinical trial.

Clinical Trials


1 Evolution of Maxillofacial Trauma Activity During COVID-19 Containment Measures: a French Multicentric Comparative Observational Study

The COVID-19 global pandemic has led to a major professional and social national reorganization: professional because it involves a redeployment of medical staff and material resources, and social because it imposes prolonged containment measures on an entire population. The maxillofacial trauma activity is mainly linked to sports or leisure accidents, fights and road accidents. It seems to appear since the beginning of containment measures a significant drop in maxillofacial trauma activity at the national level, which, if it is demonstrated in a significant way in several French hospital centers, would allow to redeploy the material and human resources related to this activity on sectors in tension due to the pandemic.

NCT04355442 Maxillofacial Injuries Skull Fractures COVID-19 Procedure: Facial fractures reduction or osteosynthesis
MeSH:Maxillofacial Injuries Skull Fractures

Primary Outcomes

Description: evolution of number of maxillofacial trauma during COVID-19 first month of containment measures compared to the same period in 2018 and 2019.the number of patients from different investigator centers operated for a facial fracture occurring between March 16, 2020 and April 15, 2020 will be compared to the number of patients in these same centers operated for a facial fracture during the same period in 2018 and in 2019. A sub-group analysis, by center, will also be carried out.

Measure: evolution of number of maxillofacial trauma

Time: 1 year

Secondary Outcomes

Description: study of variability in terms of type of trauma with and without confinement.

Measure: variability in terms of type of trauma

Time: 1 year

Description: Comparative assessment of types of trauma by the inter-regional variability : study of the inter-regional variability of maxillofacial trauma

Measure: Comparative assessment of types of trauma by the inter-regional variability

Time: 1 year


HPO Nodes